163 related articles for article (PubMed ID: 21446990)
1. β-d-Glucan kinetics for the assessment of treatment response in Pneumocystis jirovecii pneumonia.
Held J; Wagner D
Clin Microbiol Infect; 2011 Jul; 17(7):1118-22. PubMed ID: 21446990
[TBL] [Abstract][Full Text] [Related]
2. Serum (1 → 3)-β-D-glucan measurement as an early indicator of Pneumocystis jirovecii pneumonia and evaluation of its prognostic value.
Held J; Koch MS; Reischl U; Danner T; Serr A
Clin Microbiol Infect; 2011 Apr; 17(4):595-602. PubMed ID: 20673271
[TBL] [Abstract][Full Text] [Related]
3. High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia.
Jin F; Liu XH; Chen WC; Fan ZL; Wang HL
Int J Infect Dis; 2019 Nov; 88():141-148. PubMed ID: 31442630
[TBL] [Abstract][Full Text] [Related]
4. Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia.
Koo S; Baden LR; Marty FM
Clin Microbiol Infect; 2012 May; 18(5):E122-7. PubMed ID: 22404638
[TBL] [Abstract][Full Text] [Related]
5. Point-Counterpoint: Should Serum β-d-Glucan Testing Be Used for the Diagnosis of Pneumocystis jirovecii Pneumonia?
Corsi-Vasquez G; Ostrosky-Zeichner L; Pilkington EF; Sax PE
J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31434728
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis.
Del Corpo O; Butler-Laporte G; Sheppard DC; Cheng MP; McDonald EG; Lee TC
Clin Microbiol Infect; 2020 Sep; 26(9):1137-1143. PubMed ID: 32479781
[TBL] [Abstract][Full Text] [Related]
7. Association between circulating DNA, serum (1->3)-β-D-glucan, and pulmonary fungal burden in Pneumocystis pneumonia.
Costa JM; Botterel F; Cabaret O; Foulet F; Cordonnier C; Bretagne S
Clin Infect Dis; 2012 Jul; 55(2):e5-8. PubMed ID: 22523258
[TBL] [Abstract][Full Text] [Related]
8. Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients.
Zhang F; Chen J; Huang H; Deng X; Zhang W; Zeng M; Liu R; Dai L; Wan Q
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1933-1942. PubMed ID: 33880744
[TBL] [Abstract][Full Text] [Related]
9. Negative serum (1,3) -β-D-glucan has a low power to exclude Pneumocystis jirovecii pneumonia (PJP) in HIV-uninfected patients with positive qPCR.
Huang Y; Yi J; Song JJ; Du LJ; Li XM; Cheng LL; Yan SX; Li HL; Liu YM; Zhan HT; Dou YL; Li YZ
Ann Clin Microbiol Antimicrob; 2023 Nov; 22(1):102. PubMed ID: 37986091
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of a (1,3)-beta-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients.
Del Bono V; Mularoni A; Furfaro E; Delfino E; Rosasco L; Miletich F; Viscoli C
Clin Vaccine Immunol; 2009 Oct; 16(10):1524-6. PubMed ID: 19692624
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of (1→3)β-D glucan in early diagnosing Pneumocystis jirovecii pneumonia: a case report.
Atalay MA; Koc AN; Kaynar LG; Inci M; Kasap Tekinsen FF; Eser B
Infez Med; 2014 Mar; 22(1):57-61. PubMed ID: 24651093
[TBL] [Abstract][Full Text] [Related]
12. Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study.
Shimizu Y; Sunaga N; Dobashi K; Fueki M; Fueki N; Makino S; Mori M
BMC Infect Dis; 2009 Apr; 9():47. PubMed ID: 19383170
[TBL] [Abstract][Full Text] [Related]
13. Beta-glucan for Pneumocystis pneumonia diagnosis in persons with AIDS: authors' reply.
Wood BR; Komarow L; Zolopa AR; Finkelman MA; Powderly WG; Sax PE
AIDS; 2013 Nov; 27(18):2967-8. PubMed ID: 25119691
[No Abstract] [Full Text] [Related]
14. Serum (1 → 3) β-D-glucan assay for discrimination between Pneumocystis jirovecii pneumonia and colonization.
Tasaka S; Kobayashi S; Yagi K; Asami T; Namkoong H; Yamasawa W; Ishii M; Hasegawa N; Betsuyaku T
J Infect Chemother; 2014 Nov; 20(11):678-81. PubMed ID: 25066434
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers.
Esteves F; Calé SS; Badura R; de Boer MG; Maltez F; Calderón EJ; van der Reijden TJ; Márquez-Martín E; Antunes F; Matos O
Clin Microbiol Infect; 2015 Apr; 21(4):379.e1-10. PubMed ID: 25630458
[TBL] [Abstract][Full Text] [Related]
16. Serum (1->3)-{beta}-D-Glucan assay for the diagnosis of Pneumocystis jiroveci pneumonia.
Del Palacio A; Cuétara MS; Llenas-García J; Alvarez ME; Chaves F; Pulido F; Catalán M; Pontón J; Del Bono V; Viscoli C
Clin Vaccine Immunol; 2010 Jan; 17(1):202-3; author reply 203. PubMed ID: 20044649
[No Abstract] [Full Text] [Related]
17. Clinical Performance of BAL Metagenomic Next-Generation Sequence and Serum (1,3)-β-D-Glucan for Differential Diagnosis of
Liu L; Yuan M; Shi Y; Su X
Front Cell Infect Microbiol; 2021; 11():784236. PubMed ID: 35004353
[TBL] [Abstract][Full Text] [Related]
18. (1-3)-beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients.
Esteves F; Lee CH; de Sousa B; Badura R; Seringa M; Fernandes C; Gaspar JF; Antunes F; Matos O
Eur J Clin Microbiol Infect Dis; 2014 Jul; 33(7):1173-80. PubMed ID: 24487911
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis jirovecii infection: Cell wall (1→3)-β-D-glucan biology and diagnostic utility.
Finkelman MA
Crit Rev Microbiol; 2010 Nov; 36(4):271-81. PubMed ID: 20854193
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia.
Nakamura H; Tateyama M; Tasato D; Haranaga S; Yara S; Higa F; Ohtsuki Y; Fujita J
Intern Med; 2009; 48(4):195-202. PubMed ID: 19218768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
